Home
Clinical Resources Search
The PQI Podcast S4 Ep 4: Pediatric Oncology

S4 Ep 4: Pediatric Oncology

Last Updated: February 9, 2023

By: Ginger Blackmon, PharmD | Tara Higgins, PharmD

We are excited to bring you our first podcast with Continuing Education credit for pharmacists and pharmacy technicians!

In this episode, we sit down with Tara Higgins, PharmD, to discuss pediatric oncology. Dr. Higgins serves as assistant professor of pharmacy practice at LECOM School of Pharmacy in Bradenton, FL.

Frequently Searched

Supported by

S4 Ep 4: Pediatric Oncology

Find Similar Resources

PQI in Action: Larotrectinib (Vitrakvi®) Overview

PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management

PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations

PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease

PQI Podcast S5 Ep 4: Fertility Preservation

PQI: Fertility and the Oncology Patient

PQI: Sodium Thiosulfate Injection (PEDMARK®) To Prevent Platinum-Induced Ototoxicity in Pediatric and Adolescent or Young Adult (AYA) Patients

PQI Podcast S5 Ep 4: Fertility Preservation

PQI Podcast S5 Ep 5: Childhood Illness

PQI Podcast S5 Ep 8: Childhood Cancer Awareness Month

The PQI Podcast S4 Ep 10: Oncology Wellness & Exercise

S8 Ep 6: Empowering Cancer Survivors & Caregivers with Manta Cares

PQI Podcast S5 Ep 11: City of Hope Survivorship

PQI Podcast S5 Ep 15: Thinking Our Way to Chronic Health

Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings

Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure

Example SOPs and Documents: Bispecific T-Cell Engager Ordering and REMS Compliance

Example SOPs and Documents: On-Call Responsibilities for Nurses Managing Bispecific T-Cell Engagers